Creative Biolabs offers CellRapeutics™ Chimeric Antigen Receptor (CAR) production service with the highest quality. As a leading service provider, our experienced scientists are glad to provide highly customized, reliable and effective solutions for our customers.
T cells play a critical role in cell-mediated immunity, which can attack and kill cancer cells. However, cancer cells can usually avoid being attacked by T cells via a series of defense mechanisms. Recently, genetically modified T cell immunotherapy which targets tumor via directly recognizing tumor associated antigen, has become one of the most attractive approaches for treating various cancers.
A classic CAR molecule usually composes of a single chain antibody (scFv) domain, a transmembrane domain and cytoplasmic signaling domains. After the CAR-T cells being infused back into cancer patients, these modified T cells can directly recognize and kill the cancer cells which display tumor specific antigens. Experts from Creative Biolabs have successfully established cutting-edge CARs T cells construction platform, which can fit your application purpose according to the requirement.
Creative Biolabs has rich experience in developing CARs. Our skilled scientists and technicians guarantee that we can offer you unparalleled CARs-T cell construction services.
Fred Hutchinson Cancer Research Center website and Turtle CJ, Hudecek M, Jensen MC, Riddell SR. Engineered T cells for anti-cancer therapy. Curr Opin Immunol. 2012 Oct; 24(5):633-9.
For any technical issues or products/services related questions, please leave your contacts as below, and our team will contact you at earliest convenience to let you know how we can be involved in your projects.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.LEARN MORE
End-to-end CAR Hybrid TCR (CHyT)-T Cell Therapy Development Services: A novel solution to engineer T cell to be a promising cellular therapy product with the complete TCR complex without HLA matching dependence.LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.LEARN MORE